檢索結果 - Bernhard Ludvik

Refine Results
  1. 1
    Efficacy of <i>Ipomoea batatas</i> (Caiapo) on Diabetes Control in Type 2 Diabetic Subjects Treated With Diet

    Efficacy of <i>Ipomoea batatas</i> (Caiapo) on Diabetes Control in Type 2 Diabetic Subjects Treated With Diet 由 Bernhard Ludvik, Beatrice Neuffer, Giovanni Pacini

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Feasibility of a Mobile Phone–Based Data Service for Functional Insulin Treatment of Type 1 Diabetes Mellitus Patients

    Feasibility of a Mobile Phone–Based Data Service for Functional Insulin Treatment of Type 1 Diabetes Mellitus Patients 由 A. Kollmann, Michaela Riedl, Peter Kästner, G. Schreier, Bernhard Ludvik

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test

    A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test 由 Andrea Mari, Giovanni Pacini, Elaine Murphy, Bernhard Ludvik, John J. Nolan

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Prevalence of Micronutrient Deficiency after Bariatric Surgery

    Prevalence of Micronutrient Deficiency after Bariatric Surgery 由 Eva-Christina Krzizek, Johanna Brix, Alexander Stöckl, Verena Parzer, Bernhard Ludvik

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone

    Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone 由 John J. Nolan, Bernhard Ludvik, P. Beerdsen, M. Joyce, Jerrold M. Olefsky

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Increased Plasma Visfatin Concentrations in Morbidly Obese Subjects Are Reduced after Gastric Banding

    Increased Plasma Visfatin Concentrations in Morbidly Obese Subjects Are Reduced after Gastric Banding 由 Dominik G. Haider, Karin Schindler, Georg Schaller, Gerhard Prager, Michael Wolzt, Bernhard Ludvik

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Bacterial Endotoxin Induces Biphasic Changes in Plasma Ghrelin in Healthy Humans

    Bacterial Endotoxin Induces Biphasic Changes in Plasma Ghrelin in Healthy Humans 由 Greisa Vila, Christina Maier, Michaela Riedl, P. Nowotny, Bernhard Ludvik, Anton Luger, Martin Clodi

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Intravenous calcitriol normalizes insulin sensitivity in uremic patients

    Intravenous calcitriol normalizes insulin sensitivity in uremic patients 由 Alexandra Kautzky‐Willer, Giovanni Pacini, Ursula Barnas, Bernhard Ludvik, C Streli, Helmut Graf, R. Prager

    出版 1995
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Increased plasma leptin in gestational diabetes

    Increased plasma leptin in gestational diabetes 由 Alexandra Kautzky‐Willer, Giovanni Pacini, Andrea Tura, Christian Bieglmayer, Barbara Schneider, Bernhard Ludvik, Rudolf Prager, W. Waldhäusl

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.

    Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. 由 Bernhard Ludvik, John J. Nolan, A J Roberts, J Baloga, M. Joyce, Jo Bell, Jerrold M. Olefsky

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Detecting Body Fat–A Weighty Problem BMI versus Subcutaneous Fat Patterns in Athletes and Non-Athletes

    Detecting Body Fat–A Weighty Problem BMI versus Subcutaneous Fat Patterns in Athletes and Non-Athletes 由 Renate Kruschitz, Sandra J. Wallner‐Liebmann, Michael J. Hamlin, M. Moser, Bernhard Ludvik, W. Schnedl, Erwin Tafeit

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

    Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans 由 E Hartter, Thomas Svoboda, Bernhard Ludvik, M. Schüller, B. Lell, E Küenburg, M Brunnbauer, W. Woloszczuk, Rudolf Prager

    出版 1991
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients

    The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients 由 Greisa Vila, Michaela Riedl, Christian Anderwald, Michael Resl, Ammon Handisurya, Martin Clodi, Gerhard Prager, Bernhard Ludvik, Michael Krebs, Anton Luger

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity

    CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity 由 Joakim Huber, Florian W. Kiefer, Maximilian Zeyda, Bernhard Ludvik, Gerd R. Silberhumer, Gerhard Prager, Gerhard J. Zlabinger, Thomas M. Stulnig

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss

    The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss 由 Renate Kruschitz, Maria Luger, Christian Kienbacher, Michael Trauner, Carmen Klammer, Karin Schindler, Felix B. Langer, Gerhard Prager, Michael Krebs, Bernhard Ludvik

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery

    Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery 由 Christian Anderwald, Andrea Tura, Miriam Promintzer‐Schifferl, Gerhard Prager, Marietta Stadler, Bernhard Ludvik, Harald Esterbauer, Martin Bischof, Anton Luger, Giovanni Pacini, Michael Krebs

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency

    Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency 由 Maria Luger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix B. Langer, Karin Schindler, Tanja Würger, Friedrich Wrba, Michael Trauner, Gerhard Prager, Bernhard Ludvik

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes

    Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes 由 Marc P. Bonaca, Andrei‐Mircea Catarig, Yasemin Hansen, Kim Christian Houlind, Chethana Ramesh, Bernhard Ludvik, Joakim Nordanstig, Neda Rasouli, Harald Sourij, Subodh Verma

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance

    Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance 由 Michaela Riedl, Greisa Vila, Christina Maier, Ammon Handisurya, Soheila Shakeri-Manesch, Gerhard Prager, Oswald Wagner, Alexandra Kautzky‐Willer, Bernhard Ludvik, Martin Clodi, Anton Luger

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial

    Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial 由 Bernhard Ludvik, Juan P. Frías, Francisco J. Tinahones, Julio Wainstein, Honghua Jiang, Kenneth E. Robertson, Luis‐Emilio García‐Pérez, D. Bradley Woodward, Zvonko Miličević

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: